Covalent Modification and Time-Dependent Inhibition of Human CYP2E1 by the meta-Isomer of Acetaminophen
Authors:
- John P. HarrelsonJHJohn P. Harrelson
- Brendan D. StamperBSBrendan D. Stamper
- John D. ChapmanJCJohn D. Chapman
- David R. GoodlettDGDavid R. Goodlett
- Sidney D. NelsonSNSidney D. Nelson
- 1 August 2012
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 40 (8) , 1460-1465
Abstract
The hypothesis that N-acetyl-m-aminophenol (AMAP), the meta isomer of acetaminophen, will covalently bind to and inhibit human CYP2E1 in a time- and NADPH-dependent manner was investigated. Liquid chromatography/electrospray ionization-mass spectrometry analysis indicated that AMAP metabolites (i.e., AMAP*) selectively and covalently modified CYP2E1 apoprotein in a ratio of 1.4:1 (AMAP*/CYP2E1) in a reconstituted system. The deconvoluted spectra of CYP2E1 apoprotein from incubations containing NADPH and AMAP displayed mass shifts of 167.2 ± 7.1 and 334.4 ± 6.5 Da, suggesting the addition of one and two hydroxylated AMAP metabolites to CYP2E1, respectively. Mass shifts in cytochrome P450 reductase, cytochrome b5, and heme from these samples were not observed. CYP2E1 inhibition by AMAP increased with time in the presence of NADPH; a reversible inhibition component was also observed. The results support a bioactivation process that involves formation of a hydroquinone metabolite that undergoes further oxidation to a quinone, which reacts with CYP2E1 nucleophilic residues. The data are consistent with evidence from previous studies that identified hydroxylated AMAP glutathione conjugates collected from mice and indicate that cysteine residues are the most likely sites for adduct formation. This study reports the first direct evidence of AMAP-derived hydroquinone metabolites bound to human CYP2E1.Keywords
This publication has 24 references indexed in Scilit:
- Proteomic Analysis of Acetaminophen-Induced Changes in Mitochondrial Protein Expression Using Spectral CountingChemical Research in Toxicology, 2011
- Human Cytochrome P450 2E1 Structures with Fatty Acid Analogs Reveal a Previously Unobserved Binding ModeJournal of Biological Chemistry, 2010
- Mechanisms of Acetaminophen-Induced Liver Necrosis2009
- The Conduct of in Vitro Studies to Address Time-Dependent Inhibition of Drug-Metabolizing Enzymes: A Perspective of the Pharmaceutical Research and Manufacturers of AmericaDrug Metabolism and Disposition, 2009
- Structures of Human Cytochrome P-450 2E1Journal of Biological Chemistry, 2008
- Acetaminophen and the U.S. acute liver failure study group: Lowering the risks of hepatic failureHepatology, 2004
- Oxidative Stress, Toxicology, and Pharmacology of CYP2E1Annual Review of Pharmacology and Toxicology, 2004
- Reduction of benzene metabolism and toxicity in mice that lack CYP2E1 expressionToxicology and Applied Pharmacology, 1996
- Role of CYP2E1 in the Hepatotoxicity of AcetaminophenJournal of Biological Chemistry, 1996
- Characterization of glutathione conjugates of reactive metabolites of 3'-hydroxyacetanilide, a nonhepatotoxic positional isomer of acetaminophenChemical Research in Toxicology, 1989